<DOC>
	<DOCNO>NCT02912533</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy 52-week dose JR-131 renal anemia patient chronic kidney disease ( CKD ) .</brief_summary>
	<brief_title>A Long-term Study JR-131 Renal Anemia Patients With Chronic Kidney Disease ( CKD )</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>Patients treat erythropoiesis stimulating agent . Patients complication history cardiovascular / lung / brain infarction . Patients pronounce hemorrhagic lesion .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>